Filing Details

Accession Number:
0001493152-21-003285
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-10 19:42:12
Reporting Period:
2021-02-08
Accepted Time:
2021-02-10 19:42:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318306 Abeona Therapeutics Inc. ABEO Pharmaceutical Preparations (2834) 830221517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1225978 Sco Capital Partners Llc 1330 Avenue Of The Americas, 33Rd Floor
New York NY 10019
Yes No Yes No
1294343 H Steven Rouhandeh 1330 Avenue Of The Americas, 33Rd Floor
New York NY 10019
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-08 240,000 $3.01 11,359,292 No 4 S Indirect SCO Capital Partners LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect SCO Capital Partners LLC
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020.
  2. The price reported in Column 4 is a weighted average price. The shares weresold in multiple transactions at prices ranging from $3.00 to $3.06, inclusive. TheReporting Person undertakes to provide to the Issuer, any security holder, or theStaff of the SEC, upon request, full information regarding the number of sharesdisposed at each separate price within the ranges set forth in this footnote.